Twice monthly deposits are being made from device manufacturers’ revenue, and the tax totals will be used to pay for federal healthcare reform measures, according to the report.
The tax took effect Jan. 1, and was received by vehement industry opposition.
More Articles on Devices:
Mazor Robotics to Market Spine System in Canada
Conventus Orthopaedics’ DRS Implant Receives FDA Clearance
Johnson & Johnson’s Synthes Acquisition Adds 5.6% 4Q Sales Growth
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.